 |
|
Medical and Endovascular Therapy for Intracranial Atherosclerotic Vascular Disease
John N. Whitaker, MD
From the Department of Neurology, University of Alabama at Birmingham.
Arch Neurol. 2001;58:1692-1693.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
MEANINGFUL advancement in the successful treatment of intracranial atherosclerotic
disease is a major issue facing neurologists. Already at least the third leading
cause of death and much morbidity, the relative prevalence of cerebrovascular
disease in the population is expected to increase with longer survival and
the effects of multiple disease processes. Parallelling the overall growth
of neurology and its transition from a largely diagnostic to a mixed diagnostic-therapeutic
specialty, the efforts to select and appropriately treat patients with cerebrovascular
disorders have had increased success owing to a greater understanding of vascular
biology, identification of risk factors, and the introduction of technology
for noninvasive imaging and newer treatment modalities. Despite the excitement
over novel treatment available through endovascular methods, there must be
the restraint of cautiously evaluating and welcoming new treatment approaches,
while still attempting to identify the best therapeutic interventions.
In the present exchange, Dr Chimowitz1
. . . [Full Text of this Article]
RELATED ARTICLES
Angioplasty and Stenting for Primary Treatment of Intracranial Arterial Stenoses
and
Arch Neurol. ;58():1687-1690.
FULL TEXT
Angioplasty or Stenting Is Not Appropriate as First-Line Treatment of Intracranial Stenosis
Arch Neurol. ;58():1690-1692.
FULL TEXT
|
